Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Raab

Showing results (291-300 of 427) with videos related to

Pageof 43
Sort By:
Leukemia|February 19, 2014
Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myelomaM Merz, T Hielscher, B Wagner, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 11, 2024
Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myelomaSarah Schreiner, Natalie Berghaus, Alexandra M Poos, et al.
Oncogenesis|May 16, 2017
Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activationJ Xu, N Pfarr, V Endris, et al.
Bone Marrow Transplantation|March 14, 2024
Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in GermanySandra Sauer, Monika Engelhardt, Karolin Trautmann-Grill, et al.
Journal of Hematology & Oncology|June 28, 2019
Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trialDirk Hose, Susanne Beck, Hans Salwender, et al.
European Radiology|November 28, 2024
Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myelomaChristian Neelsen, Christos Sachpekidis, Lukas John, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 30, 2022
Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple MyelomaFredrik Schjesvold, Bruno Paiva, Vincent Ribrag, et al.
Blood|November 20, 2008
Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signalingMarc S Raab, Iris Breitkreutz, Giovanni Tonon, et al.
Frontiers in Oncology|November 11, 2021
Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the PrognosisCyrus Khandanpour, Christine Eisfeld, Subbaiah Chary Nimmagadda, et al.
Haematologica|March 22, 2015
A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myelomaElias K Mai, Thomas Hielscher, Jost K Kloth, et al.
Pageof 43

Showing results (291-300 of 427) with videos related to

Sort By:
Pageof 43
Leukemia|February 19, 2014
Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myelomaM Merz, T Hielscher, B Wagner, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 11, 2024
Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myelomaSarah Schreiner, Natalie Berghaus, Alexandra M Poos, et al.
Oncogenesis|May 16, 2017
Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activationJ Xu, N Pfarr, V Endris, et al.
Bone Marrow Transplantation|March 14, 2024
Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in GermanySandra Sauer, Monika Engelhardt, Karolin Trautmann-Grill, et al.
Journal of Hematology & Oncology|June 28, 2019
Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trialDirk Hose, Susanne Beck, Hans Salwender, et al.
European Radiology|November 28, 2024
Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myelomaChristian Neelsen, Christos Sachpekidis, Lukas John, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 30, 2022
Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple MyelomaFredrik Schjesvold, Bruno Paiva, Vincent Ribrag, et al.
Blood|November 20, 2008
Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signalingMarc S Raab, Iris Breitkreutz, Giovanni Tonon, et al.
Frontiers in Oncology|November 11, 2021
Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the PrognosisCyrus Khandanpour, Christine Eisfeld, Subbaiah Chary Nimmagadda, et al.
Haematologica|March 22, 2015
A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myelomaElias K Mai, Thomas Hielscher, Jost K Kloth, et al.
Pageof 43